Hazard Assessment and Risk Estimation of Inhaled Nanomaterials Exposure

吸入纳米材料暴露的危害评估和风险评估

基本信息

  • 批准号:
    7852941
  • 负责人:
  • 金额:
    $ 65.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-26 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Engineered nanomaterials (ENM) have the potential to revolutionize every-day life due to unique properties that have led to advances in electronics, materials science, and drug delivery. Many types of ENM are produced by the metric ton per year and, thus, exposures in occupational and environmental settings are likely. The respiratory tract is a primary route of entry for ENM in such exposure settings. Recent in vitro and in vivo studies have demonstrated the ability of ENM to induce oxidative stress, inflammatory and profibrotic mediator release, and pathology. However, the long-term consequences of ENM exposures at realistic concentrations in humans are unclear because short-term testing is often done at unreasonably high doses and/or under unrealistic conditions. This project is aimed at characterizing risk from realistic human exposures to ENM. Research Plan: We hypothesize that inhaled ENM induce inflammation in the lungs through their oxidative stress-inducing potential that is related to their reactive surface properties and that the ensuing pulmonary inflammatory response enhances translocation to and effects in secondary target sites such as pleura and central nervous system. Furthermore, we hypothesize that rapid screening assays can be developed that are predictive of short- and long-term health outcomes if they are related to relevant mechanisms of toxicity at realistic doses. Our objectives are to assess the predictability of short-term acellular, cellular in vitro, and in vivo assays for long-term adverse health outcomes in the respiratory tract and to quantitate ENM translocation- related effects in secondary tissues following realistic inhalation exposure using a multidisciplinary tiered testing approach. The objectives to test the hypothesis will be met with four Specific Aims to: 1) evaluate workplace ENM exposures; 2) use acellular systems to assess the characteristics and oxidative reactivity of ENM; 3) compare pulmonary and secondary tissue responses to and biokinetics of ENM following single and repeated respiratory tract exposures in rats under realistic conditions using a novel aerosolization system; and 4) evaluate ENM dose-response relationships in cultured primary and secondary organ target cells using doses that are derived from in vivo biokinetics studies of inhaled ENM. Extensive correlation analyses will be done to test a new concept of a response metric that can be used to reliably compare outcome measures from different short-term tests. Expected Results: We expect that acellular and cellular assays of ENM activity will correlate with and be predictive of target cell inflammatory responses, lung inflammation, and secondary organ responses in vivo. These results, as well as information about exposure levels at workplaces and about the persistence of ENM in lung and secondary target tissues, can be used for preliminary risk estimations of the long-term adverse human health outcomes related to ENM exposure and as a basis for more extensive risk assessment. PUBLIC HEALTH RELEVANCE: The use of engineered nanomaterials (ENM) in consumer products has raised concerns about risks to human health following release into workplaces or the environment and some recent studies have described adverse outcomes following in vitro and in vivo exposures. We will conduct comprehensive studies - including workplace exposure characterizations, acellular ENM functional characterizations, in vitro tests of effects in cultured target cells, and in vivo effects and material distribution studies in rodents - to assess dose-related effects in the lung, pleura, and central nervous system following realistic inhalation exposures to ENM that are delivered in their native state without additional surface modifications. These results will be used to develop and validate short-term tests that can be used for estimating potential human risk following ENM exposure.
描述(由申请人提供):工程纳米材料 (ENM) 因其独特的特性而有可能彻底改变日常生活,这些特性促进了电子、材料科学和药物输送领域的进步。许多类型的 ENM 每年产生数吨,因此可能会在职业和环境环境中暴露。在此类暴露环境中,呼吸道是 ENM 进入的主要途径。最近的体外和体内研究表明,ENM 具有诱导氧化应激、炎症和促纤维化介质释放以及病理学的能力。然而,人类实际浓度的 ENM 暴露的长期后果尚不清楚,因为短期测试通常是在不合理的高剂量和/或不切实际的条件下进行的。该项目旨在描述人类实际暴露于 ENM 的风险。研究计划:我们假设吸入的 ENM 通过其氧化应激诱导潜力(与其反应性表面特性相关)诱导肺部炎症,并且随后的肺部炎症反应增强了胸膜和中枢神经等次要目标部位的易位和影响系统。此外,我们假设,如果与实际剂量下的相关毒性机制相关,则可以开发出可预测短期和长期健康结果的快速筛查方法。我们的目标是评估短期非细胞、细胞体外和体内检测对呼吸道长期不良健康结果的可预测性,并使用多学科的方法定量真实吸入暴露后继发组织中 ENM 易位相关的影响。分层测试方法。检验假设的目标将通过四个具体目标来实现:1)评估工作场所 ENM 暴露; 2)利用非细胞系统评估ENM的特性和氧化反应性; 3) 使用新型雾化系统,在真实条件下比较大鼠单次和重复呼吸道暴露后 ENM 的肺和继发组织反应和生物动力学; 4) 使用源自吸入 ENM 体内生物动力学研究的剂量评估培养的初级和次级器官靶细胞中的 ENM 剂量-反应关系。将进行广泛的相关分析来测试响应指标的新概念,该概念可用于可靠地比较不同短期测试的结果测量。预期结果:我们预计 ENM 活性的非细胞和细胞测定将与体内靶细胞炎症反应、肺部炎症和次级器官反应相关并可预测。这些结果以及有关工作场所暴露水平以及有关肺和次要目标组织中 ENM 持久性的信息,可用于对与 ENM 暴露相关的长期不良人类健康结果进行初步风险评估,并作为更广泛的风险评估。 公共健康相关性:工程纳米材料 (ENM) 在消费品中的使用引发了人们对释放到工作场所或环境中对人类健康造成风险的担忧,最近的一些研究描述了体外和体内暴露后的不良后果。我们将进行全面的研究,包括工作场所暴露特征、非细胞 ENM 功能特征、培养靶细胞效应的体外测试以及啮齿类动物的体内效应和材料分布研究,以评估肺、胸膜和肺部的剂量相关效应。真实吸入暴露于 ENM 后的中枢神经系统,ENM 以其自然状态传递,无需额外的表面修饰。这些结果将用于开发和验证短期测试,可用于估计 ENM 暴露后潜在的人类风险。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alison Elder其他文献

Alison Elder的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alison Elder', 18)}}的其他基金

Glymphatic impairment as a crucial factor in particulate matter exposure related development of Alzheimer's disease pathology
类淋巴系统损伤是与颗粒物暴露相关的阿尔茨海默病病理学发展的关键因素
  • 批准号:
    10718104
  • 财政年份:
    2023
  • 资助金额:
    $ 65.02万
  • 项目类别:
International Nanotoxicology Congress: Nanotox 2016
国际纳米毒理学大会:Nanotox 2016
  • 批准号:
    9195226
  • 财政年份:
    2016
  • 资助金额:
    $ 65.02万
  • 项目类别:
Impact of Ambient Ultrafine Particle Exposures on Alzheimer's Disease Progression
环境超细颗粒暴露对阿尔茨海默病进展的影响
  • 批准号:
    8502926
  • 财政年份:
    2013
  • 资助金额:
    $ 65.02万
  • 项目类别:
Impact of Ambient Ultrafine Particle Exposures on Alzheimer's Disease Progression
环境超细颗粒暴露对阿尔茨海默病进展的影响
  • 批准号:
    9065942
  • 财政年份:
    2013
  • 资助金额:
    $ 65.02万
  • 项目类别:
Impact of Ambient Ultrafine Particle Exposures on Alzheimer's Disease Progression
环境超细颗粒暴露对阿尔茨海默病进展的影响
  • 批准号:
    8731894
  • 财政年份:
    2013
  • 资助金额:
    $ 65.02万
  • 项目类别:
Impact of Ambient Ultrafine Particle Exposures on Alzheimer's Disease Progression
环境超细颗粒暴露对阿尔茨海默病进展的影响
  • 批准号:
    8852615
  • 财政年份:
    2013
  • 资助金额:
    $ 65.02万
  • 项目类别:
Impact of Ambient Ultrafine Particle Exposures on Alzheimer's Disease Progression
环境超细颗粒暴露对阿尔茨海默病进展的影响
  • 批准号:
    9278171
  • 财政年份:
    2013
  • 资助金额:
    $ 65.02万
  • 项目类别:
Hazard Assessment and Risk Estimation of Inhaled Nanomaterials Exposure
吸入纳米材料暴露的危害评估和风险评估
  • 批准号:
    7939792
  • 财政年份:
    2009
  • 资助金额:
    $ 65.02万
  • 项目类别:
Hazard Assessment and Risk Estimation of Inhaled Nanomaterials Exposure
吸入纳米材料暴露的危害评估和风险评估
  • 批准号:
    8071680
  • 财政年份:
    2009
  • 资助金额:
    $ 65.02万
  • 项目类别:
Fate and Effects of Nanoparticles: Relationship to Physicochemical Properties
纳米颗粒的命运和影响:与理化性质的关系
  • 批准号:
    7341306
  • 财政年份:
    2007
  • 资助金额:
    $ 65.02万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目

相似海外基金

Project 1: Translational Studies on Temperature and Solvent Effects on Electronic Cigarette-Derived Oxidants
项目1:温度和溶剂对电子烟氧化剂影响的转化研究
  • 批准号:
    10665896
  • 财政年份:
    2023
  • 资助金额:
    $ 65.02万
  • 项目类别:
The impact of a neonicotinoid pesticide on neural functions underlying learning and memory
新烟碱类农药对学习和记忆神经功能的影响
  • 批准号:
    10646631
  • 财政年份:
    2023
  • 资助金额:
    $ 65.02万
  • 项目类别:
Neural Recording and Simulation Tools to Address the Mesoscale Gap
解决中尺度差距的神经记录和模拟工具
  • 批准号:
    10739544
  • 财政年份:
    2023
  • 资助金额:
    $ 65.02万
  • 项目类别:
Vaccinating at Mucosal Surfaces with Nanoparticle-conjugated Antigen and Adjuvant
使用纳米颗粒结合的抗原和佐剂在粘膜表面进行疫苗接种
  • 批准号:
    10587388
  • 财政年份:
    2023
  • 资助金额:
    $ 65.02万
  • 项目类别:
Preclinical development of a synthetic lung surfactant dry powder aerosol for hypoxemia or acute respiratory distress syndrome patients receiving different modes of ventilation support
用于接受不同通气支持模式的低氧血症或急性呼吸窘迫综合征患者的合成肺表面活性剂干粉气雾剂的临床前开发
  • 批准号:
    10658610
  • 财政年份:
    2023
  • 资助金额:
    $ 65.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了